{"DataElement":{"publicId":"2785858","version":"1","preferredName":"Residual Disease Ovarian Carcinoma Category","preferredDefinition":"Category to represent the size in millimeters of the largest remaining nodule of ovarian carcinoma. [Manually-curated]","longName":"RESID_OVAR_CA_CAT","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2013006","version":"1","preferredName":"Residual Disease Extent","preferredDefinition":"Measurement of the amount of residual disease remaining.","longName":"RESID_DIS_EXTENT","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2206424","version":"1","preferredName":"Residual Diseases and Disorders","preferredDefinition":"Remaining or left behind.:A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C37895:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual","conceptCode":"C37895","definition":"Remaining or left behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F4AE-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177500","version":"1","preferredName":"Extent","preferredDefinition":"The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","longName":"Extent","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Extent","conceptCode":"C25332","definition":"The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51ED-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7785040-DD32-5E13-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-08-05","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2785852","version":"1","preferredName":"Ovarian Carcinoma Residual Disease Category","preferredDefinition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms. --2002_Cancer cells that remain after attempts to remove the cancer have been made._Category; used informally to mean a class of things.","longName":"OVAR_CA_RESID_DZ_CAT","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":">20 mm","valueDescription":"Maximum diameter of largest remaining nodule more than 20 mm in size","ValueMeaning":{"publicId":"2785853","version":"1","preferredName":"Maximum diameter of largest remaining nodule more than 20 mm in size","longName":"2785853","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than nineteen and less than twenty-one and the quantity that it denotes.: A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Twenty","conceptCode":"C105799","definition":"A natural number greater than nineteen and less than twenty-one and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Millimeter","conceptCode":"C28251","definition":"A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5728B967-A176-1D11-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/05/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5728B967-A18F-1D11-E044-0003BA3F9857","beginDate":"2008-09-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-18","modifiedBy":"REEVESD","dateModified":"2008-09-18","deletedIndicator":"No"},{"value":"11-20 mm","valueDescription":"Maximum diameter of largest remaining nodule 11-20 mm in size","ValueMeaning":{"publicId":"2785854","version":"1","preferredName":"Maximum diameter of largest remaining nodule 11-20 mm in size","longName":"2785854","preferredDefinition":"A natural number greater than 10 and less than 12 and the quantity that it denotes.: Used as a function word to indicate direction, purpose, or movement.: A natural number greater than nineteen and less than twenty-one and the quantity that it denotes.: A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eleven","conceptCode":"C113425","definition":"A natural number greater than 10 and less than 12 and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Twenty","conceptCode":"C105799","definition":"A natural number greater than nineteen and less than twenty-one and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Millimeter","conceptCode":"C28251","definition":"A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5728B967-A19B-1D11-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/05/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5728B967-A1B4-1D11-E044-0003BA3F9857","beginDate":"2008-09-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-18","modifiedBy":"REEVESD","dateModified":"2008-09-18","deletedIndicator":"No"},{"value":"1-10 mm","valueDescription":"Maximum diameter of largest remaining nodule 1-10 mm in size","ValueMeaning":{"publicId":"2785855","version":"1","preferredName":"Maximum diameter of largest remaining nodule 1-10 mm in size","longName":"2785855","preferredDefinition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.: Used as a function word to indicate direction, purpose, or movement.: A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.: A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"One","conceptCode":"C66832","definition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ten","conceptCode":"C69122","definition":"A natural number greater than 9 and less than 11 and the quantity that it denotes: the sum of nine and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Millimeter","conceptCode":"C28251","definition":"A metric unit of length equal to one thousandth of a meter (10E-3 meter) or approximately 0.03937 inch.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5728B967-A1C0-1D11-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/05/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5728B967-A1D9-1D11-E044-0003BA3F9857","beginDate":"2008-09-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-18","modifiedBy":"REEVESD","dateModified":"2008-09-18","deletedIndicator":"No"},{"value":"None","valueDescription":"No residual disease","ValueMeaning":{"publicId":"2785856","version":"1","preferredName":"No residual disease","longName":"2785856","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5728B967-A1E5-1D11-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/05/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5728B967-A1FE-1D11-E044-0003BA3F9857","beginDate":"2008-09-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-18","modifiedBy":"REEVESD","dateModified":"2008-09-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2785851","version":"1","preferredName":"Ovarian Carcinoma Residual Disease Category","preferredDefinition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms. --2002:Cancer cells that remain after attempts to remove the cancer have been made.:Category; used informally to mean a class of things.","longName":"C4908:C4809:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Carcinoma","conceptCode":"C4908","definition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Residual Disease","conceptCode":"C4809","definition":"Tumor cells that remain in the body following cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5728B967-A151-1D11-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-18","modifiedBy":"ONEDATA","dateModified":"2008-09-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5728B967-A162-1D11-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-18","modifiedBy":"REEVESD","dateModified":"2011-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787515","version":"1","longName":"PAAD","context":"NCIP"},{"publicId":"3787505","version":"1","longName":"HNSC","context":"NCIP"},{"publicId":"3787508","version":"1","longName":"KIRP","context":"NCIP"},{"publicId":"3787513","version":"1","longName":"LUSC","context":"NCIP"},{"publicId":"3787514","version":"1","longName":"OV","context":"NCIP"},{"publicId":"3787516","version":"1","longName":"PRAD","context":"NCIP"},{"publicId":"3787502","version":"1","longName":"CESC","context":"NCIP"},{"publicId":"3787503","version":"1","longName":"COAD","context":"NCIP"},{"publicId":"3787504","version":"1","longName":"GBM","context":"NCIP"},{"publicId":"3787506","version":"1","longName":"KICH","context":"NCIP"},{"publicId":"3787507","version":"1","longName":"KIRC","context":"NCIP"},{"publicId":"3787499","version":"1","longName":"BLCA","context":"NCIP"},{"publicId":"3787500","version":"1","longName":"BRCA","context":"NCIP"},{"publicId":"3787510","version":"1","longName":"LGG","context":"NCIP"},{"publicId":"3787509","version":"1","longName":"LAML","context":"NCIP"},{"publicId":"3787511","version":"1","longName":"LIHC","context":"NCIP"},{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"},{"publicId":"3787512","version":"1","longName":"LUAD","context":"NCIP"},{"publicId":"3787517","version":"1","longName":"READ","context":"NCIP"},{"publicId":"3787518","version":"1","longName":"SARC","context":"NCIP"},{"publicId":"3787520","version":"1","longName":"STAD","context":"NCIP"},{"publicId":"3787522","version":"1","longName":"UCEC","context":"NCIP"},{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"}]}],"AlternateNames":[{"name":"Tumor Residual Disease","type":"TCGA_Name","context":"NCIP"},{"name":"tumor_residual_disease","type":"TCGA_XML_Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Tumor residual disease: ovary","type":"Preferred Question Text","description":"Tumor residual disease: ovary","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5728D86B-BB16-296C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-18","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Reviewed and approved for Release by TCGA team 1/8/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}